Lock; Christopher James

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lock; Christopher James.The latest application filed is for "amido thiadiazole derivatives as nadph oxidase inhibitors".

Company Profile

2.15.14

Lock; Christopher James - Burwell GB
LOCK; CHRISTOPHER JAMES - SAFFRON WALDEN GB
Lock; Christopher James - Slough GB
Lock; Christopher James - Berkshire GB
Lock; Christopher James - Cambridge GE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome Grant 10,307,422 - Burli , et al.	2019-06-04
Amido Thiadiazole Derivatives As Nadph Oxidase Inhibitors App 20190046515 - MACHIN; PETER ; et al.	2019-02-14
Amido thiadiazole derivatives as NADPH oxidase inhibitors Grant 10,130,619 - Machin , et al. November 20, 2	2018-11-20
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome App 20180207159 - BURLI; Roland Werner ; et al.	2018-07-26
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome Grant 9,925,187 - Burli , et al. March 27, 2	2018-03-27
Amido Thiadiazole Derivatives As Nadph Oxidase Inhibitors App 20170348296 - MACHIN; PETER ; et al.	2017-12-07
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome Grant 9,783,545 - Burli , et al. October 10, 2	2017-10-10
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome App 20170143718 - BURLI; Roland Werner ; et al.	2017-05-25
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome Grant 9,549,910 - Burli , et al. January 24, 2	2017-01-24
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome App 20160272647 - BURLI; Roland Werner ; et al.	2016-09-22
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher syndrome Grant 9,371,332 - Burli , et al. June 21, 2	2016-06-21
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome App 20160158172 - BURLI; Roland Werner ; et al.	2016-06-09
Pyrazolopyridazines and methods for treating retinal degenerative diseases and hearing loss associated with usher syndrome Grant 9,260,381 - Burli , et al. February 16, 2	2016-02-16
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome Grant 9,227,976 - Burli , et al. January 5, 2	2016-01-05
Pyrazolopyridazines And Methods For Treating Retinal Degenerative Diseases And Hearing Loss Associated With Usher Syndrome App 20150266812 - BURLI; Roland Werner ; et al.	2015-09-24
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome App 20150265617 - BURLI; Roland Werner ; et al.	2015-09-24
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher Syndrome Grant 9,079,909 - Burli , et al. July 14, 2	2015-07-14
Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndrome Grant 8,765,762 - Burli , et al. July 1, 2	2014-07-01
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome App 20140121197 - BURLI; Roland Werner ; et al.	2014-05-01
Pyrazolopyridazines And Methods For Treating Retinal-degerative Diseases And Hearing Loss Associated With Usher Syndrome App 20140121205 - Burli; Roland Werner ; et al.	2014-05-01
Fused pyridine derivatives as kinase inhibitors Grant 8,653,272 - Jenkins , et al. February 18, 2	2014-02-18
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome App 20130252936 - BURLI; Roland Werner ; et al.	2013-09-26
Quinoxaline and quinoline derivatives as kinase inhibitors Grant 8,399,483 - Allen , et al. March 19, 2	2013-03-19
Fused Pyridine Derivatives as Kinase Inhibitors App 20110201630 - Jenkins; Kerry ; et al.	2011-08-18
Quinoxaline And Quinoline Derivatives As Kinase Inhibitors App 20110105508 - Allen; Daniel Rees ; et al.	2011-05-05
2 Amino-Pyrimidine Derivatives As H4 Receptor Antagonists, Processes For Preparing Them And Their Use In Pharmaceutical Compositions App 20100035863 - Raphy; Gilles ; et al.	2010-02-11
Racemization and asymmetric transformation processes used in the manufacture of levobupivacaine and analogues thereof Grant 5,786,484 - Dyer , et al. July 28, 1	1998-07-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.